Hof, Lotta
Moreth, Till
Koch, Michael
Liebisch, Tim
Kurtz, Marina
Tarnick, Julia
Lissek, Susanna M.
Verstegen, Monique M. A.
van der Laan, Luc J. W.
Huch, Meritxell
Matthäus, Franziska
Stelzer, Ernst H. K.
Pampaloni, Francesco http://orcid.org/0000-0003-4357-7320
Funding for this research was provided by:
Horizon 2020 Framework Programme (668350-2)
Deutsche Forschungsgemeinschaft (CEF-MC2)
Giersch Foundation
Bundesministerium für Bildung und Forschung (114027003)
Hessisches Ministerium für Wissenschaft und Kunst (LOEWE DynaMem, CMMS, DynaMem, CMMS)
Article History
Received: 31 August 2020
Accepted: 12 January 2021
First Online: 24 February 2021
Ethics approval and consent to participate
: The Ethics Approval REC No. 12/EE/0253 from the UK National Research Ethics Service (NRES) covers the ethical issues involved the generation and culture of the murine pancreas-derived organoids used in the LSFM4LIFE project and in this work. Medical ethical approval for the use of patient liver tumour biopsies for research purposes has been granted by the Medical Ethical Committee (METC) of the Erasmus Medical Center in Rotterdam, The Netherlands (MEC-2014-060). Patients provided written informed consent and all methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: FP and EHKS have been granted a patent on the ultra-thin FEP-foil cuvettes (US9816916B2).